Covestor’s Recursion Pharmaceuticals RXRX Stock Holding History

Covestor’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Buy	35 +16	+84%	+$62	﹤0.01%	2719
2025 Q4	$0	Hold	19	–	–	﹤0.01%	2692
2025 Q3	$0	Hold	19	–	–	﹤0.01%	2717
2025 Q2	$0	Sell	19 -2	-10%	-$10	﹤0.01%	2685
2025 Q1	$0	Hold	21	–	–	﹤0.01%	2666
2024 Q4	$0	Buy	21 +9	+75%	+$61	﹤0.01%	2674
2024 Q3	$0	Sell	12 -1	-8%	-$7	﹤0.01%	2686
2024 Q2	$0	Hold	13	–	–	﹤0.01%	2684
2024 Q1	$0	Sell	13 -1	-7%	-$11	﹤0.01%	2677
2023 Q4	$0	Sell	14 -2	-13%	-$14	﹤0.01%	2659
2023 Q3	$0	Sell	16 -2	-11%	-$20	﹤0.01%	2648
2023 Q2	$0	Hold	18	–	–	﹤0.01%	2593
2023 Q1	$0	Hold	18	–	–	﹤0.01%	2516
2022 Q4	$0	Sell	18 -2	-10%	-$20	﹤0.01%	2536
2022 Q3	$0	Sell	20 -12	-38%	-$122	﹤0.01%	2513
2022 Q2	$0	Buy	32 +7	+28%	+$47	﹤0.01%	2314
2022 Q1	$0	Sell	25 -7	-22%	-$74	﹤0.01%	2441
2021 Q4	$1K	Buy	+32	New	+$602	﹤0.01%	1909

Other funds holding RXRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return